This compound is supplied exclusively for scientific investigation and analytical laboratory use
Comparing cardiovascular benefits between GLP-1 receptor agonists and SGLT2 inhibitors as an add-on to metformin among patients with type 2 diabetes: a retrospective cohort study
Book An Appointment Stories From Our Glow Community Discover the real experiences of clients who found renewed energy, beauty, and balance with our treatments
Macrophages, Chronic Inflammation, and Insulin Resistance
"Anabolic effects of insulin-like growth factor-I (IGF-I) and an IGF-I variant in normal female rats." Journal of Endocrinology 137.3(1993):413-421
Research Applications HIV-associated lipodystrophy and visceral adiposity reduction Metabolic syndrome and visceral obesity research Growth hormone axis and GHRH receptor research Body composition and regional fat distribution studies Cardiovascular risk factor reduction research Metabolic complications of antiretroviral therapy studies Age-related visceral fat accumulation research Lipid metabolism and dyslipidemia research Insulin resistance and glucose metabolism studies Sarcopenic obesity and body composition research Quality of life and body image research in lipodystrophy GHRH analog pharmacology and development research Safety Profile Tesamorelin has an established safety profile from extensive clinical trial experience and post-marketing surveillance, with the medication carrying specific warnings and requiring careful patient monitoring particularly for glucose metabolism and malignancy screening
